SEBI Registration No - INA000003197 Investment in stock and commodity market are subject to market risk. Please do not trade on those tips which are not provided through SMS.



Top 16 stocks in focus today: Sun Pharma, Axis Bank, Adlabs, Akzo Nobel

Sun Pharmaceutical’s subsidiary Taro Pharma reported a strong performance during the previous quarter.ONGC has sought higher gas prices from the government for a block it plans to develop in the KG Basin, warning that it will otherwise have to mothball the $600 million-project,Telecom stocks in focus today as Trai is considering removal of the 50% limit on spectrum holdings within a particular band, as per media reports.Reliance Communications is renegotiating its deal with Canadian investment fund Brookfield along with other potential buyers for a stake in its tower unit, as per media reports.Axis Bank board to meet on Nov 10 to consider raising funds.

Three Pillars PTE to sell up to 19.99 crore shares of Bharti Airtel in the range of Rs 473-480 per share.

Adlabs to sell Novotel Imagica Khopoli Hotel for Rs 213 crore to Bright Star. It will also sell Walkwater stake to Blue Haven for Rs 150 crore.

Indoco Remedies to resume manufacturing of ophthalmic products at Goa unit II.

Akzo Nobel to divest India’s specialty chemical business, likely to garner for Rs 320 crore.

JSW Energy got an order to supply 200 MW power to Karnataka from November 8 – May 31.

DCM Shriram to invest around Rs 500 crore in sugar business to increase overall capacity.

NMDC mulls bidding for $9 billion mine, as per media reports.

ICICI Bank is on course to monetize its third subsidiary in about two years as it prepares to list ICICI Securities, the investment banking and broking unit, on the stock exchanges.

Rekha Rakesh Jhunjhunwala sold 25 lakh shares or 0.9% equity stake at Rs 280.35 each of Delta Corp. Small Cap World Fund bought 1.02 crore shares or 3.8% equity stake at Rs 279.2 each (average).

GSK Consumer has reported 4.73% increase in net profit at Rs 192.41 crore for the second quarter ended September 30, 2017-18. It had posted net profit of Rs 183.72 crore in the same period of last fiscal, 2016-17.

IOB has reported widening of its net loss by nearly 60% at Rs 1,222.50 crore for second quarter ended September.

F&O Ban; In ban: DHFL, HDIL, Indiabulls Real Estate, India Cement, Infibeam, JSW Energy, Reliance Communication, Wockhardt; New in ban: India Cement.